|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2010-9-10
|
|
pubmed:abstractText |
Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy (R-CHOP) has improved survival in patients with diffuse large B-cell lymphoma (DLBCL) and weakened the prognostic power of the international prognostic index (IPI). We evaluated the efficacy of the IPI and revised IPI (R-IPI) in patients with DLBCL who were treated with R-CHOP, focusing on extranodal site number (ENS) because extranodal involvement occurs frequently in Koreans.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1226-3303
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
25
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
301-8
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:20830228-Adolescent,
pubmed-meshheading:20830228-Adult,
pubmed-meshheading:20830228-Aged,
pubmed-meshheading:20830228-Aged, 80 and over,
pubmed-meshheading:20830228-Antibodies, Monoclonal,
pubmed-meshheading:20830228-Antibodies, Monoclonal, Murine-Derived,
pubmed-meshheading:20830228-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:20830228-Cyclophosphamide,
pubmed-meshheading:20830228-Doxorubicin,
pubmed-meshheading:20830228-Female,
pubmed-meshheading:20830228-Humans,
pubmed-meshheading:20830228-Korea,
pubmed-meshheading:20830228-Lymphoma, Large B-Cell, Diffuse,
pubmed-meshheading:20830228-Male,
pubmed-meshheading:20830228-Middle Aged,
pubmed-meshheading:20830228-Prednisone,
pubmed-meshheading:20830228-Prognosis,
pubmed-meshheading:20830228-Retrospective Studies,
pubmed-meshheading:20830228-Vincristine,
pubmed-meshheading:20830228-Young Adult
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Modified number of extranodal involved sites as a prognosticator in R-CHOP-treated patients with disseminated diffuse large B-cell lymphoma.
|
|
pubmed:affiliation |
Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
|
|
pubmed:publicationType |
Journal Article
|
